• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human RGPD8/RGPD4/RGPD3 Polyclonal Antibody

The antibody against RGPD8/RGPD4/RGPD3 was raised in rabbit using the Synthesized peptide derived from the C-terminal region of Human RGPD2/3/4/6/8. as the immunogen. This antibody exists as a non-conjugated isotype IgG. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on WB, ELISA.

ADC-33847A

The antibody against RGPD8/RGPD4/RGPD3 was raised in rabbit using the Synthesized peptide derived from the C-terminal region of Human RGPD2/3/4/6/8. as the immunogen. This antibody exists as a non-conjugated isotype IgG. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This antibody has been validated on WB, ELISA.

$167.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-33847A ClonalityPolyclonal
Host SpeciesRabbitTarget NameRGPD8/RGPD4/RGPD3
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.5% BSA and 0.02% sodium azide., Liquid in PBS containing 50% glycerol
Purification MethodThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.ConjugateNon-conjugated
ApplicationELISA, WBStorageUpon receipt

Immunogen Information


Immunogen DescriptionSynthesized peptide derived from the C-terminal region of Human RGPD2/3/4/6/8.Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDO14715, Q53T03, Q7Z3J3, A6NKT7, P0C839

Inquire Rabbit anti-Human RGPD8/RGPD4/RGPD3 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification